Long-term inflammation and glucocorticoid therapy impair skeletal modeling during growth in childhood crohn disease

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 8, 2013, Pages 3438-3445

  Tsampalieros, Anne ^a,b   Lam, Carol K L ^d   Spencer, Jenna C ^e   Thayu, Meena ^b,f   Shults, Justine ^b,c   Zemel, Babette S ^b   Herskovitz, Rita M ^b   Baldassano, Robert N ^b   Leonard, Mary B ^b,c  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF ILLINOIS   (United States)

^f MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; GLUCOCORTICOID; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; VITAMIN D;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE DISEASE; BONE GROWTH; BONE LENGTH; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICAL BONE; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GROWTH DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE DIAGNOSIS; SCORING SYSTEM; TIBIA; TRABECULAR BONE;

ADOLESCENT; ADULT; BONE DENSITY; BONE DEVELOPMENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROHN DISEASE; FEMALE; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; MALE; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84881528941     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1631     Document Type: Article

References (31)

1. Leonard MB, Elmi A, Mostoufi-Moab S, et al. Effects of sex, race, and puberty on cortical bone and the functional muscle bone unit in children, adolescents, and young adults. J Clin Endocrinol Metab. 2010;95:1681-1689.
2. Seeman E, Delmas PD. Bone quality-the material and structural basis of bone strength and fragility.NEngl J Med. 2006;354:2250-2261.
3. Seeman E. Pathogenesis of bone fragility inwomenand men. Lancet. 2002;359:1841-1850.
4. Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoidinduced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007;18:1319-1328.
5. Rauch A, Seitz S, Baschant U, et al. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell metabolism. 2010;11:517-531.
6. Gilbert L, He X, Farmer P, et al. Expression of the osteoblast differentiation factorRUNX2(Cbfa1/AML3/Pebp2α A) is inhibited by tumor necrosis factor-α. J Biol Chem. 2002;277:2695-2701.
7. Ahuja SS, Zhao S, Bellido T, Plotkin LI, Jimenez F, Bonewald LF. CD40 ligand blocks apoptosis induced by tumor necrosis factor α, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4. Endocrinology. 2003;144: 1761-1769.
8. Kudo O, Fujikawa Y, Itonaga I, Sabokbar A, Torisu T, Athanasou NA. Proinflammatory cytokine (TNFα/IL-1α) induction of human osteoclast formation. J Pathol. 2002;198:220-227.
9. Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y. IL-6, RANKL, TNF-α/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 2004;15:49-60.
10. Dubner SE, Shults J, Baldassano RN, et al. Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease. Gastroenterology. 2009;136:123-130.
11. Thayu M, Denson LA, Shults J, et al. Determinants of changes in linear growth and body composition in incident pediatric Crohn's disease. Gastroenterology. 2010;139:430-438.
12. Prosnitz AR, Leonard MB, Shults J, et al. Changes in vitamin D and parathyroid hormone metabolism in incident pediatric Crohn's disease. Inflamm Bowel Dis. 2013;19:45-53.
13. Tanner J, Whitehouse R, Marshall W, Healy M, Goldstein H. Assessment of Skeletal Maturity and Prediction of Adult Height (TW2 Method). London, United Kingdom: Academic Press; 1975.
14. Morris NM, Udry J. Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolesc. 1980;9: 271-280.
15. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439-447.
16. Kontulainen SA, Johnston JD, Liu D, Leung C, Oxland TR, McKay HA. Strength indices from pQCT imaging predict up to 85% of variance in bone failure properties at tibial epiphysis and diaphysis. J Musculoskelet Neuronal Interact. 2008;8:401-409.
17. Hollis BW. Quantitation of 25-hydroxy vitamin D and 1, 25-dihydroxy vitamin D by radioimmunoassay using radioiodinated tracers. Methods Enzymol. 1997;282:174-186.
18. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002;109:45-60.
19. Cole TJ. TheLMSmethod for constructing normalized growth standards. Eur J Clin Nutr. 1990;44:45-60.
20. Zemel BS, Leonard MB, Kelly A, et al. Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab. 2010;95:1265-1273.
21. Mostoufi-Moab S, Brodsky J, Isaacoff EJ, et al. Longitudinal assessment of bone density and structure in childhood survivors of acute lymphoblastic leukemia without cranial radiation. J Clin Endocrinol Metab. 2012;97:3584-3592.
22. Fitzmaurice GM, Laird NM. Applied Longitudinal Analysis. 2nd ed. Hoboken, NJ: John Wiley, Sons, Inc; 2011.
23. Gafni RI, McCarthy EF, Hatcher T, et al. Recovery from osteoporosis through skeletal growth: early bone mass acquisition has little effect on adult bone density. FASEB J. 2002;16:736-738.
24. Prentice A, Parsons TJ, Cole TJ. Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants. Am J Clin Nutr. 1994; 60:837-842.
25. Werkstetter KJ, Pozza SB, Filipiak-Pittroff B, et al. Long-term development of bone geometry and muscle in pediatric inflammatory bowel disease. Am J Gastroenterol. 2011;106:988-998.
26. Terpstra AM, Kalkwarf HJ, Shults J, et al. Bone density and cortical structure after pediatric renal transplantation. J Am Soc Nephrol. 2012;23:715-726.
27. Tsampalieros A, Gupta P, DenburgMR, et al. Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome. J Bone Miner Res. 2013;28(3):480-488.
28. Schweizer R, Martin DD, Schwarze CP, et al. Cortical bone density is normal in prepubertal children with growth hormone (GH) deficiency, but initially decreases during GH replacement due to early bone remodeling. J Clin Endocrinol Metab. 2003;88:5266-5272.
29. Ducher G, Bass SL, Saxon L, Daly RM. Effects of repetitive loading on the growth-induced changes in bone mass and cortical bone geometry: a 12-month study in pre/peri-and postmenarcheal tennis players. J Bone Miner Res. 2011;26:1321-1329.
30. Kontulainen S, Sievanen H, Kannus P, Pasanen M, Vuori I. Effect of long-term impact-loading on mass, size, and estimated strength of humerus and radius of female racquet-sports players: a peripheral quantitative computed tomography study between young and old starters and controls. J Bone Miner Res. 2002;17:2281-2289.
31. Tuchman S, Thayu M, Shults J, Zemel BS, Burnham JM, Leonard MB. Interpretation of biomarkers of bone metabolism in children: impact of growth velocity and body size in healthy children and chronic disease. J Pediatr. 2008;153:484-490.